The present invention relates to a double-stranded oligo RNA structure comprising double-stranded miRNA, and a composition for preventing or treating cancer, containing the same. More specifically, the present invention relates to an anti-cancer pharmaceutical composition, containing: a double-stranded oligo RNA structure comprising miR-3670, miR-4477a and miR-8078, and characterized by a method for effectively inhibiting cancer cell proliferation or inducing cancer cell apoptosis; and a pharmaceutically acceptable carrier.
本发明涉及一种包含双链 miRNA 的双链寡聚 RNA 结构,以及一种含有该结构的预防或治疗癌症的组合物。更具体地说,本发明涉及一种抗癌药物组合物,其中含有:包含 miR-3670、miR-4477a 和 mi
R-8078 的双链寡核苷酸结构,其特征在于可有效抑制癌细胞增殖或诱导癌细胞凋亡;以及药学上可接受的载体。